Global Bio-pharma Market 2024-2028

The bio-pharma market is forecasted to grow by USD 204.09 bn during 2023-2028, accelerating at a CAGR of 7.98% during the forecast period. The report on the bio-pharma market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of health disorders, the growing geriatric population, and the targeted therapeutic mechanism of biologics.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.35%
CAGR	7.98%
Incremental Value	$204.09bn

Technavio's bio-pharma market is segmented as below:

By Product

Monoclonal antibodies
Recombinant growth factors
Vaccines
Recombinant hormones
Others

By Application

Oncology
Autoimmune disorder
Metabolic disorder
Hormonal disorder
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rise in the production of vaccines as one of the prime reasons driving the bio-pharma market growth during the next few years. Also, growing investments in the life sciences sector and a growing number of acquisitions by market vendors will lead to sizable demand in the market.

The report on the bio-pharma market covers the following areas:

Bio-pharma market sizing
Bio-pharma market forecast
Bio-pharma market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bio-pharma market vendors that include AbbVie Inc., Amgen Inc., Angelini S.p.a., AspenBio, Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Ipsen Pharma, Johnson and Johnson, Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Vertex Pharmaceuticals Inc.. Also, the bio-pharma market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR77011

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global bio-pharma market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global bio-pharma market 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Monoclonal antibodies - Market size and forecast 2023-2028
Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
6.4 Recombinant growth factors - Market size and forecast 2023-2028
Exhibit 38: Chart on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
6.5 Vaccines - Market size and forecast 2023-2028
Exhibit 42: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
6.6 Recombinant hormones - Market size and forecast 2023-2028
Exhibit 46: Chart on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Recombinant hormones - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Recombinant hormones - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ billion)
Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Application

7.1 Market segments
Exhibit 56: Chart on Application - Market share 2023-2028 (%)
Exhibit 57: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 58: Chart on Comparison by Application
Exhibit 59: Data Table on Comparison by Application
7.3 Oncology - Market size and forecast 2023-2028
Exhibit 60: Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
7.4 Autoimmune disorder - Market size and forecast 2023-2028
Exhibit 64: Chart on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
7.5 Metabolic disorder - Market size and forecast 2023-2028
Exhibit 68: Chart on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Metabolic disorder - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Metabolic disorder - Year-over-year growth 2023-2028 (%)
7.6 Hormonal disorder - Market size and forecast 2023-2028
Exhibit 72: Chart on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Data Table on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
Exhibit 74: Chart on Hormonal disorder - Year-over-year growth 2023-2028 (%)
Exhibit 75: Data Table on Hormonal disorder - Year-over-year growth 2023-2028 (%)
7.7 Others - Market size and forecast 2023-2028
Exhibit 76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 78: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 79: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Application
Exhibit 80: Market opportunity by Application ($ billion)
Exhibit 81: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 83: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 85: Chart on Geographic comparison
Exhibit 86: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 103: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 115: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 116: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 117: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 118: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 121: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 125: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 127: Overview on factors of disruption
11.4 Industry risks
Exhibit 128: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 129: Vendors covered
12.2 Market positioning of vendors
Exhibit 130: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 131: AbbVie Inc. - Overview
Exhibit 132: AbbVie Inc. - Product / Service
Exhibit 133: AbbVie Inc. - Key news
Exhibit 134: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 135: Amgen Inc. - Overview
Exhibit 136: Amgen Inc. - Product / Service
Exhibit 137: Amgen Inc. - Key offerings
12.5 Astellas Pharma Inc.
Exhibit 138: Astellas Pharma Inc. - Overview
Exhibit 139: Astellas Pharma Inc. - Product / Service
Exhibit 140: Astellas Pharma Inc. - Key news
Exhibit 141: Astellas Pharma Inc. - Key offerings
12.6 AstraZeneca Plc
Exhibit 142: AstraZeneca Plc - Overview
Exhibit 143: AstraZeneca Plc - Product / Service
Exhibit 144: AstraZeneca Plc - Key news
Exhibit 145: AstraZeneca Plc - Key offerings
12.7 Bayer AG
Exhibit 146: Bayer AG - Overview
Exhibit 147: Bayer AG - Business segments
Exhibit 148: Bayer AG - Key news
Exhibit 149: Bayer AG - Key offerings
Exhibit 150: Bayer AG - Segment focus
12.8 Biogen Inc.
Exhibit 151: Biogen Inc. - Overview
Exhibit 152: Biogen Inc. - Product / Service
Exhibit 153: Biogen Inc. - Key offerings
12.9 Bristol Myers Squibb Co.
Exhibit 154: Bristol Myers Squibb Co. - Overview
Exhibit 155: Bristol Myers Squibb Co. - Product / Service
Exhibit 156: Bristol Myers Squibb Co. - Key news
Exhibit 157: Bristol Myers Squibb Co. - Key offerings
12.10 Eli Lilly and Co.
Exhibit 158: Eli Lilly and Co. - Overview
Exhibit 159: Eli Lilly and Co. - Product / Service
Exhibit 160: Eli Lilly and Co. - Key news
Exhibit 161: Eli Lilly and Co. - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 162: F. Hoffmann La Roche Ltd. - Overview
Exhibit 163: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 164: F. Hoffmann La Roche Ltd. - Key news
Exhibit 165: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 166: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Johnson and Johnson
Exhibit 167: Johnson and Johnson - Overview
Exhibit 168: Johnson and Johnson - Business segments
Exhibit 169: Johnson and Johnson - Key news
Exhibit 170: Johnson and Johnson - Key offerings
Exhibit 171: Johnson and Johnson - Segment focus
12.13 Novartis AG
Exhibit 172: Novartis AG - Overview
Exhibit 173: Novartis AG - Business segments
Exhibit 174: Novartis AG - Key offerings
Exhibit 175: Novartis AG - Segment focus
12.14 Novo Nordisk AS
Exhibit 176: Novo Nordisk AS - Overview
Exhibit 177: Novo Nordisk AS - Business segments
Exhibit 178: Novo Nordisk AS - Key offerings
Exhibit 179: Novo Nordisk AS - Segment focus
12.15 Pfizer Inc.
Exhibit 180: Pfizer Inc. - Overview
Exhibit 181: Pfizer Inc. - Product / Service
Exhibit 182: Pfizer Inc. - Key news
Exhibit 183: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 184: Sanofi SA - Overview
Exhibit 185: Sanofi SA - Business segments
Exhibit 186: Sanofi SA - Key news
Exhibit 187: Sanofi SA - Key offerings
Exhibit 188: Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 189: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 190: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 191: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 192: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 193: Inclusions checklist
Exhibit 194: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 195: Currency conversion rates for US$
13.4 Research methodology
Exhibit 196: Research methodology
Exhibit 197: Validation techniques employed for market sizing
Exhibit 198: Information sources
13.5 List of abbreviations
Exhibit 199: List of abbreviations